Rising R&D in The Pharmaceutical Sector Propelling the European Drug Discovery Informatics Market

Published: Mar 2021

European drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The growing research activities such as the implementation of pilot projects related to the Drug Supply Chain Security Act in the region are further supporting the growth of the European drug discovery informatics market. In February 2019, a consortium of various universities including Frankfurt University of Applied Sciences, RheinMain University of Applied Sciences, Fulda University of Applied Sciences, and operational partners including Bayer AG, Boehringer Ingelheim Pharma GmbH & Co. KG, and GEFCO Forwarding Germany GmbH has developed a validated web-based platform called MYTIGATE.

Browse the full report description European Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/europe-drug-discovery-informatics-market

Moreover, the adoption of AI technology by the various pharmaceutical companies for the drug discoveries further offers ample opportunity to the market. For instance, in November 2016, Janssen Pharmaceutical NV partnered with BenevolentAI Ltd. BenevolentAI Ltd. licensed the right to develop, manufacture, and commercialize clinical-stage drug candidates from Janssen after using artificial intelligence to identify untapped potential in Janssen's portfolio. In May 2018, Roche starts working on drug discovery using AI with Owkin. Therefore, the significant presence of the major pharma companies that are actively engaged in drug discovery along with the adoption of AI analytics solutions in the country is anticipated to drive the growth of the market in Europe.

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Function and by End-User

Regions Covered

UK, Germany, France Italy, Spain, and the Rest of Europe

Key Companies Profiled

Accenture PLC, Dassault Systèmes SE, Eurofins GSC Lux SARL, Evotec SE, Selvita S.A, and others.

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment/region dominates the market in the base year?
  • Which segment/region will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected region/segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

European Drug Discovery Informatics Market – Segmentation

By Function

  • Docking
  • Molecular Modeling
  • Libraries and Database Preparation
  • Sequencing and Target Data Analysis
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others (Research Institutes) 

European Drug Discovery Informatics Market – Segmentation by Geography 

  • UK
  • Germany
  • France 
  • Italy
  • Spain
  • Rest of Europe

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/europe-drug-discovery-informatics-market